Compound Detail
CHEMBL1200689
NITRIC OXIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1200689 |
| Name | NITRIC OXIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MWUXSHHQAYIFBG-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
3
Publications
9
Known Names
20
Indications
1
Mechanisms
Molecular Properties
30.0
MW (Da)
-0.45
ALogP
1
HBA
0
HBD
39.4
PSA (Ų)
0.36
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1999 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Soluble guanylate cyclase activator | ACTIVATOR | Soluble guanylate cyclase | ✓ | ✓ |
Indications
Hypertension, Pulmonary Hypertension, Pulmonary Respiratory Insufficiency Respiratory Insufficiency Respiratory Tract Diseases Acute Kidney Injury Brain Injuries Bronchiolitis Bronchopulmonary Dysplasia Diabetic Foot Hernias, Diaphragmatic, Congenital Hypoxia Hypoxia Leishmaniasis, Cutaneous Lung Diseases Persistent Fetal Circulation Syndrome Pneumonia Pneumonia, Aspiration Premature Birth Reperfusion Injury
ATC Classification
R07AX01
nitric oxide
Level 1: RESPIRATORY SYSTEM
Level 2: OTHER RESPIRATORY SYSTEM PRODUCTS
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 16248836 | 10.2174/138920005774330639 | Cytochrome P450 2C11 | 1 |
| 16248836 | 10.2174/138920005774330639 | Cytochrome P450 3A2 | 1 |
Data from ChEMBL 36 via Core Engine